LLY

1,094.16

-1.85%↓

JNJ

227.79

-2.55%↓

ABBV

216.12

-2.62%↓

UNH

401.72

-1.63%↓

NVS

147.21

-3.22%↓

LLY

1,094.16

-1.85%↓

JNJ

227.79

-2.55%↓

ABBV

216.12

-2.62%↓

UNH

401.72

-1.63%↓

NVS

147.21

-3.22%↓

LLY

1,094.16

-1.85%↓

JNJ

227.79

-2.55%↓

ABBV

216.12

-2.62%↓

UNH

401.72

-1.63%↓

NVS

147.21

-3.22%↓

LLY

1,094.16

-1.85%↓

JNJ

227.79

-2.55%↓

ABBV

216.12

-2.62%↓

UNH

401.72

-1.63%↓

NVS

147.21

-3.22%↓

LLY

1,094.16

-1.85%↓

JNJ

227.79

-2.55%↓

ABBV

216.12

-2.62%↓

UNH

401.72

-1.63%↓

NVS

147.21

-3.22%↓

Search

Inmode Ltd

Open

SectorHealthcare

13.38 -0.67

Overview

Share price change

24h

Current

Min

13.3

Max

13.53

Key metrics

By Trading Economics

Income

-15M

12M

Sales

-22M

82M

P/E

Sector Avg

10.052

49.712

EPS

0.25

Profit margin

14.097

Employees

660

EBITDA

-17M

15M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+16.75% upside

Dividends

By Acuity

Next Earnings

29 lip 2026

Market Stats

By TradingEconomics

Market Cap

-81M

825M

Previous open

14.05

Previous close

13.38

News Sentiment

By Acuity

50%

50%

155 / 342 Ranking in Healthcare

Inmode Ltd Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

About Inmode Ltd

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.
help-icon Live chat